Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Eli Lilly & Co. (NY: LLY)
51.37 USD  -0.98 (-1.87%)
Official Closing Price  /  Updated: 4:15 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Eli Lilly & Co.
 
< Previous 1 2 3 4 5 6 7 8 9
...
83 84 Next >
Eli Lilly Issues Alert for Two Illegal Scans Involving Co. Name
Today 15:17 EDT
Eli Lilly and Company (NYSE: LLY ) today issued an alert about two illegal scams, purportedly using the name of the company and/or its subsidiary Elanco Animal Health, that are actively targeting the... Read More
category Benzinga , News , LLY
from Latest Articles from Benzinga.com
UPDATE 1-AstraZeneca, Bristol diabetes drug disappoints in key test
Today 2:55 EDT
LONDON, June 19 (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might... Read More
category companyNews
from Reuters: Company News
UPDATE 3-FDA probes deaths of two patients on Lilly schizophrenia drug
June 18, 2013
June 18 (Reuters) - The U.S. Food and Drug Administration is investigating the cases of two individuals who died after injections with Eli Lilly and Co.'s long-acting treatment for schizophrenia,... Read More
category companyNews
from Reuters: Company News
Daily Dividend Report: SRE, LLY, AMAT, RL, PETM
June 18, 2013
This afternoon, Sempra Energy (SRE) declared its quarterly dividend of 63 cents per share, maintaining the amount paid to shareholders the last quarter. Based on the current stock price, investors can... Read More
category Dividends
from Dividend Channel
Eli Lilly (LLY) Breaks Through Support at $52.02
June 18, 2013
from Comtex SmarTrend® News Briefs
Eli Lilly & Co. (LLY) Declares $0.49 Quarterly Dividend; 3.8% Yield
June 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8426855 for the full story. Read More
from StreetInsider.com News Articles
CORRECTED-Eli Lilly studying deaths of two patients on long-acting Zyprexa
June 18, 2013
June 18 (Reuters) - The U.S. Food and Drug Administration on Tuesday said it was investigating deaths of two patients who died following injections with Eli Lilly and Co's long-acting treatment for... Read More
category companyNews
from Reuters: Company News
FDA Investigating Two Deaths Following Injection of Lilly's (LLY) Antipsychotic Zyprexa Relprevv
June 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8426765 for the full story. Read More
from StreetInsider.com News Articles
Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market
June 18, 2013
category Pharmaceuticals
from Trefis
Lilly Scraps An Alzheimer's Drug; What Does It Mean For Merck?
June 14, 2013
Once again, Eli Lilly has suffered a setback trying to find a useful drug to combat Alzheimer’s. Last year, a pair of late-stage trials for an injectable drug called solanezumab failed to meet primary... Read More
category NYSE:MRK , NYSE:LLY
from Forbes Real Time
StreetInsider.com Pre-Open Movers 6/14: (RH) (GRPN) (ELN) Higher; (CEMP) (HIMX) (RBCN) Lower (more...)
June 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8417561 for the full story. Read More
from StreetInsider.com News Articles
StreetInsider.com After-Hours Movers 6/13: (RH) (SWHC) (OCN) Higher; (CPST) (GNRC) (LLY) Lower (more...)
June 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8416298 for the full story. Read More
from StreetInsider.com News Articles
UPDATE 1-Lilly halts Alzheimer's drug trial due to liver problems
June 13, 2013
June 13 (Reuters) - Eli Lilly and Co. said on Thursday it halted a mid-stage study of an experimental Alzheimer's disease treatment due to potential liver toxicity, the latest setback in the quest to... Read More
category companyNews
from Reuters: Company News
Lilly halts Alzheimer's drug trial because of liver problems
June 13, 2013
June 13 (Reuters) - Eli Lilly and Co said on Thursday it was halting a midstage clinical trial of an experimental Alzheimer's disease treatment due to potential liver toxicity problems. Read More
category companyNews
from Reuters: Company News
Lilly and Co. (LLY) Ceases BACE Phase II Voluntarily; Sees Immaterial Charge
June 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8415785 for the full story. Read More
from StreetInsider.com News Articles
The $65M woman
June 13, 2013
Pepper Hamilton partner Nina Gussack controls about $65 million in business, roughly 20 percent of the firm’s revenues, according to a Q&A with The Careerist, a blog examining at how lawyers shape... Read More
category Philadelphia , Legal Services , Eli Lilly& Co/ , and 8 more.
from Business Journals
Lilly says arthritis pill effective in mid-stage study
June 13, 2013
June 13 (Reuters) - Eli Lilly and Co and Incyte Corp said their experimental drug was effective in reducing painful symptoms associated with rheumatoid arthritis after 52 weeks of treatment. Read More
category companyNews
from Reuters: Company News
Lilly, Incyte Announce Baricitinib Efficacy and Safety Data from Phase 2b JADA Study in Patients with Rheumatoid Arthritis
June 13, 2013
Eli Lilly and Company (NYSE: LLY ) and Incyte Corporation (NASDAQ: INCY ) today announced 52-week efficacy and safety data from the open-label, long-term extension of the Phase 2b JADA study of... Read More
category Contracts , Management , Benzinga , and 5 more.
from Latest Articles from Benzinga.com
NeuroTronik bags $1.7M to treat heart condition
June 12, 2013
Medical technology startup NeuroTronik has nabbed nearly $1.7 million in equity financing from two undisclosed investors, according to a securities filing... Read More
category Health Care , NeuroTronik , Eli Lilly and Company , and 1 more.
from Business Journals
NEJM Sheds Light On Payments To Doctors
June 11, 2013
It should come as no surprise that pharmaceutical companies pay doctors for a variety of reasons such as research, lecturing, and teaching. Such payments are justified as these physicians tend to be in... Read More
category NYSE:PFE , NYSE:LLY
from Forbes Real Time
Cloud Computing: CNBC Explains
June 10, 2013
Cloud computing means being able to access the Internet anywhere, anytime and being able to use any or all of the data and applications you want. Read More
category Salesforce/com Inc , Amazon/com Inc , Verisign Inc , and 6 more.
from CNBC.com News
15 Dividend Stocks to Buy on the Cheap
June 09, 2013
 Read More
category NYSE:JNJ , NYSE:GIS , NYSE:LMT , and 3 more.
from InvestorPlace - Latest Headlines
Stem-Cell Producer CDI Files to Go Public
June 07, 2013
 Read More
category NYSE:JPM , NYSE:GSK , NYSE:AZN , and 1 more.
from InvestorPlace - Latest Headlines
Sanofi steps up diabetes drive as rivals raise the stakes
June 07, 2013
* Investing in smart technology to bolster diabetes business Read More
category companyNews
from Reuters: Company News
Drug Company Profits Set to Increase from Additions to DSM-5 (LLY, NVS, PFE)
June 06, 2013
It’s a simple matter of math. The more diseases there are to treat, the more profit there is to be made – by drug companies that produce the medicines designed to treat those diseases. The Wall Street... Read More
category SHPG , Benzinga , General , and 13 more.
from Latest Articles from Benzinga.com
Top Ranked Dividend Stock LLY Enters Oversold Territory
June 05, 2013
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important... Read More
category Dividends
from Dividend Channel
StockCall Pre-Market Review on BMY, LLY, ENDP, and AGN
June 05, 2013
from ACCESSWIRE
Battleground FDA: How Tomorrow's Avandia Panel Could Help Shape The Future Of Diabetes
June 04, 2013
Avandia, once the best-selling diabetes pill on the planet, is now given only to a few thousand Americans. In much of the rest of the world it has been pulled from the market because of analyses that... Read More
category NYSE:SNY , NYSE:NVO , NYSE:GSK , and 2 more.
from Forbes Real Time
Lilly (LLY) Says PRONOUNCE Missed Primary Superiority Endpoint
June 03, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8384273 for the full story. Read More
from StreetInsider.com News Articles
UPDATE 1-Longer tamoxifen use reduces breast cancer recurrence
June 02, 2013
CHICAGO, June 2 (Reuters) - Breast cancer is less likely to recur if women previously treated for the disease take the drug tamoxifen for 10 years, instead of the recommended five years, according to a... Read More
category companyNews
from Reuters: Company News
< Previous 1 2 3 4 5 6 7 8 9
...
83 84 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here